Replimune's RP1 treatment for advanced melanoma faces FDA rejection due to trial design issues, despite promising results ...

Freedom from university diktats is allowing campuses to catch up with the times — updating curricula and aligning education ...

VISTA, an AI-controlled data loop system, guides large-scale antibody design from scratch for applications in cancer therapy.

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...

Prof. Jiangfan Yu's team at the School of Science and Engineering, The Chinese University of Hong Kong (Shenzhen), has ...

Lifezoom, a pioneer of red light therapy in the USA, is excited to expand with the new industry-leading Veyra Series, red ...

Announcing a new publication for Acta Materia Medica journal. Bioresponsive materials have gained prominence as innovative ...

This application note explores how researchers successfully combined AI with advanced multiplexed gene synthesis to design ...

For decades, the narrative around Parkinson’s disease treatment has focused primarily on dopamine replacement. The loss of dopaminergic neurons in the substantia nigra is well recognized and drives ...

David Baker’s lab has successfully designed binders to disordered proteins, expanding therapeutic access to over 50% of the ...